Furthermore, the antitumor effects of KDM3A ablation were weakened by anti‐IFNAR1 antibody treatment, suggesting that KDM3A ablation suppressed tumor growth and enhanced antitumor immunity in a type I IFN dependent manner (Figure 4G–I). The gene discussed is IFNAR1; the disease is neoplasm.